Covid: Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group
NEW DELHI: An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech’s Covaxin for children in the 2 to 18 years age group with certain conditions, sources said on Tuesday.…